AIM
ACER

Acrospire Investment Management’s Acer Therapeutics Inc ACER Stock Holding History

Acrospire Investment Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-883
Closed -$38K – 2211
2016
Q2 		$38K Buy
+883
New +$26.3K 0.03% 1258

Other funds holding ACER

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Acrospire Investment Management's ACER Position: Q3 2016 in Review

Acrospire Investment Management sold out of Acer Therapeutics Inc (ACER) in Q3 2016, closing a stake of 883 shares — an estimated $38K sold.

Acrospire Investment Management first reported a position in ACER in Q2 2016 and held it in 1 quarter. The position peaked at $38K in Q2 2016. 14 funds tracked by Wall St. Rank hold ACER as of Q3 2016.

  • Acrospire Investment Management reported no remaining Acer Therapeutics Inc position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 883 Acer Therapeutics Inc shares in Q3 2016, an estimated $38K.
  • Acrospire Investment Management first reported a position in Acer Therapeutics Inc in Q2 2016 and held it in 1 quarter.
  • Acrospire Investment Management's Acer Therapeutics Inc position peaked at $38K in Q2 2016.
  • 14 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.